Edap TMS SA (EDAP)
6.95
-0.14
(-1.97%)
USD |
NASDAQ |
Apr 24, 14:28
Edap TMS Free Cash Flow (Quarterly): -5.566M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.566M |
| September 30, 2023 | -2.604M |
| June 30, 2023 | -7.739M |
| March 31, 2023 | -4.632M |
| December 31, 2022 | -7.486M |
| September 30, 2022 | 1.789M |
| June 30, 2022 | -0.3815M |
| March 31, 2022 | 0.4432M |
| Date | Value |
|---|---|
| December 31, 2021 | 2.385M |
| September 30, 2021 | 0.8098M |
| June 30, 2021 | -1.311M |
| March 31, 2021 | 1.428M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -0.0375M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-7.739M
Minimum
Jun 2023
2.385M
Maximum
Dec 2021
-1.762M
Average
-0.3815M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| DBV Technologies SA | -14.04M |
| Biophytis SA | -- |
| Cellectis SA | -17.41M |
| Adaptimmune Therapeutics PLC | -15.50M |
| NuCana PLC | 0.3701M |